Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 110

1.

Nothing's perfect: the art of defining HLA-specific antibodies.

Middleton D, Jones J, Lowe D.

Transpl Immunol. 2014 May;30(4):115-21. doi: 10.1016/j.trim.2014.02.003. Epub 2014 Feb 26. Review.

PMID:
24582684
2.
3.

Consensus guidelines on the testing and clinical management issues associated with HLA and non-HLA antibodies in transplantation.

Tait BD, Süsal C, Gebel HM, Nickerson PW, Zachary AA, Claas FH, Reed EF, Bray RA, Campbell P, Chapman JR, Coates PT, Colvin RB, Cozzi E, Doxiadis II, Fuggle SV, Gill J, Glotz D, Lachmann N, Mohanakumar T, Suciu-Foca N, Sumitran-Holgersson S, Tanabe K, Taylor CJ, Tyan DB, Webster A, Zeevi A, Opelz G.

Transplantation. 2013 Jan 15;95(1):19-47. doi: 10.1097/TP.0b013e31827a19cc.

PMID:
23238534
4.

Clinical relevance of HLA donor-specific antibodies detected by single antigen assay in kidney transplantation.

Caro-Oleas JL, González-Escribano MF, González-Roncero FM, Acevedo-Calado MJ, Cabello-Chaves V, Gentil-Govantes MÁ, Núñez-Roldán A.

Nephrol Dial Transplant. 2012 Mar;27(3):1231-8. doi: 10.1093/ndt/gfr429. Epub 2011 Aug 2.

PMID:
21810767
5.

Lights and shadows of anti-HLA antibodies detected by solid-phase assay.

Picascia A, Sabia C, Grimaldi V, Montesano ML, Sommese L, Schiano C, Napoli C.

Immunol Lett. 2014 Nov;162(1 Pt A):181-7. doi: 10.1016/j.imlet.2014.08.014. Epub 2014 Aug 27. Review.

PMID:
25171913
6.

Technical Limitations of the C1q Single-Antigen Bead Assay to Detect Complement Binding HLA-Specific Antibodies.

Taylor CJ, Kosmoliaptsis V, Martin J, Knighton G, Mallon D, Bradley JA, Peacock S.

Transplantation. 2017 Jun;101(6):1206-1214. doi: 10.1097/TP.0000000000001270.

7.

Definition of permissible and immunogenic HLA antigens based on epitope analysis of the HLA specific antibodies produced in sensitized patients.

Papassavas AC, Stavropoulos-Giokas C, Boletis J, Ioannou S, Iniotaki-Theodoraki A, Kostakis A.

Eur J Immunogenet. 2002 Oct;29(5):401-7.

PMID:
12358849
8.

Positive virtual crossmatch with negative flow crossmatch results in two cases.

Jacob EK, De Goey SR, Gandhi MJ.

Transpl Immunol. 2011 Jul;25(1):77-81. doi: 10.1016/j.trim.2011.05.007. Epub 2011 May 23.

PMID:
21641997
9.

Specific "intra-allele" and "intra-broad antigen" human leukocyte antigen alloantibodies in kidney graft transplantation.

Muro M, González-Soriano MJ, Salgado G, López R, Boix F, López M, Campillo JA, Martínez P, Botella C, Gimeno L, Minguela A, Alvarez-López MR, Llorente S.

Hum Immunol. 2010 Sep;71(9):857-60. doi: 10.1016/j.humimm.2010.05.018. Epub 2010 May 25.

PMID:
20510320
10.

C1q-fixing human leukocyte antigen assay in immunized renal patients: correlation between Luminex SAB-C1q and SAB-IgG.

Llorente S, Boix F, Eguia J, López M, Bosch A, Martinez H, Gonzalez MJ, López-Hernández R, Salgado G, Moya-Quiles MR, Campillo JA, García-Alonso AM, Minguela A, Jimeno L, Alvarez-López MR, Muro M.

Transplant Proc. 2012 Nov;44(9):2535-7. doi: 10.1016/j.transproceed.2012.09.084.

PMID:
23146446
11.

Prediction of organ transplant rejection by HLA-specific and non-HLA antibodies--brief literature review.

Slavcev A.

Int J Immunogenet. 2013 Apr;40(2):83-7. doi: 10.1111/j.1744-313X.2012.01139.x. Epub 2012 Jun 18. Review.

PMID:
22708882
12.

Intact HLA not beta2m-free heavy chain-specific HLA class I antibodies are predictive of graft failure.

Cai J, Terasaki PI, Anderson N, Lachmann N, Schönemann C.

Transplantation. 2009 Jul 27;88(2):226-30. doi: 10.1097/TP.0b013e3181ac6198.

PMID:
19623018
13.

Solid phase assays for HLA antibody detection in clinical transplantation.

Tait BD.

Curr Opin Immunol. 2009 Oct;21(5):573-7. doi: 10.1016/j.coi.2009.07.017. Epub 2009 Sep 16. Review.

PMID:
19765965
14.

The significance of pretransplant donor-specific antibodies reactive with intact or denatured human leucocyte antigen in kidney transplantation.

Otten HG, Verhaar MC, Borst HP, van Eck M, van Ginkel WG, Hené RJ, van Zuilen AD.

Clin Exp Immunol. 2013 Sep;173(3):536-43. doi: 10.1111/cei.12127.

15.

Clinical cytometry and progress in HLA antibody detection.

Bray RA, Tarsitani C, Gebel HM, Lee JH.

Methods Cell Biol. 2011;103:285-310. doi: 10.1016/B978-0-12-385493-3.00012-7. Review.

PMID:
21722808
16.

Unravelling the connections between donor specific antibodies and renal allograft pathology.

Chapman JR, Wavamunno M, O'Connell PJ, Nankivell BJ.

Clin Transpl. 2013:361-5.

PMID:
25095530
17.

Interpretation of HLA single antigen bead assays.

Ellis TM.

Transplant Rev (Orlando). 2013 Oct;27(4):108-11. doi: 10.1016/j.trre.2013.07.001. Epub 2013 Aug 17. Review.

PMID:
23958238
18.

Allosensitization to HLA and MICA is an important measure of renal graft outcome.

Panigrahi A, Siddiqui JA, Rai A, Margoob A, Khaira A, Bhowmik D, Tiwari SC, Guleria S, Mehra NK.

Clin Transpl. 2007:211-7.

PMID:
18637472
19.

Clinical relevance of pre and post-transplant immune markers in kidney allograft recipients: anti-HLA and MICA antibodies and serum levels of sCD30 and sMICA.

Solgi G, Furst D, Mytilineos J, Pourmand G, Amirzargar AA.

Transpl Immunol. 2012 Mar;26(2-3):81-7. doi: 10.1016/j.trim.2011.12.002. Epub 2011 Dec 13.

PMID:
22182633

Supplemental Content

Support Center